摘要
肿瘤相关巨噬细胞 (TAM) 位于肿瘤微环境 (TME) 中,在癌细胞存活和进展中发挥重要作用。 TAMs 通过产生炎症介质、生长因子、细胞因子、趋化因子等参与在肿瘤中产生免疫抑制性 TME。TAMs 可以影响肿瘤细胞 (TCs) 的血管生成、转移行为并引起多药耐药性。 TME 内的 TAM 可以增强癌细胞转移,并且是基质和血管周围的。在缺氧和TME的无血管区促进血管生成。 TAM 的分化状态被认为是“可塑性的”,因为它们根据局部线索表现出一种或几种表型的时间表达。新兴的癌症研究描述了巨噬细胞极化(M1、M2)的表观遗传调控及其对开发药理学调节剂和 microRNA 以充当分子开关甚至作为抑制肿瘤生长的靶向疗法的潜在影响。本文讨论了 TAM 在肿瘤进展、血管生成和转移中的作用。此外,还讨论了由 TAM 调节的关键信号级联反应,这些级联反应在化学抗性中发挥作用。目前,各种抗癌植物药物的新型多效特性正变得越来越重要,因为它们有助于克服 TAM 诱导的化学抗性。此外,这些植物药物正在与化疗剂、抗血管生成分子、抗转移化合物和其他针对肿瘤转移/血管生成的免疫检查点阻滞剂一起作为“辅助治疗剂”进行测试。因此,提供了针对 TAM 的天然产物的简要说明。总之,这篇综述将有利于药理学家和医疗专业人员使用多组学方法开发靶向 TAM 的疗法,包括基因组学、表观基因组学、转录组学和蛋白质组学。
关键词: 肿瘤相关巨噬细胞、肿瘤微环境、化学增敏作用、肿瘤血管生成、M1 和 M2、巨噬细胞、天然产物。
Current Medicinal Chemistry
Title:The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status
Volume: 28 Issue: 39
关键词: 肿瘤相关巨噬细胞、肿瘤微环境、化学增敏作用、肿瘤血管生成、M1 和 M2、巨噬细胞、天然产物。
摘要: Tumor associated macrophages (TAMs), located in the tumor microenvironment (TME), play a significant role in cancer cell survival and progression. TAMs have been involved in producing immuno-suppressive TME in the tumor by generating inflammatory mediators, growth factors, cytokines, chemokines, etc. TAMs can influence the angiogenesis, metastatic behavior of tumor cells (TCs) and cause multidrug resistance. TAMs within the TME can enhance cancer cell metastasis and are stromal and perivascular. The angiogenesis is promoted at the hypoxia, and the avascular zones of TME. Differentiation states of TAMs are considered ‘plastic’ as they exhibit temporal expression of one or several phenotypes depending on local cues. Emerging cancer research depicted the epigenetic regulation of macrophage polarization (both M1s, M2s) and their potential implications to develop pharmacologic modulators and microRNAs to act as molecular switches and even to serve as targeted therapies to inhibit tumor growth. In the present article, the role of TAMs in tumor progression, angiogenesis and metastasis was discussed. In addition, key signaling cascades regulated by TAMs, which have a role in chemoresistance, were also discussed. Currently, novel pleiotropic properties of various anticancer phytomedicines are gaining importance as they assist in overcoming TAMs-induced chemoresistance. Moreover, these phytomedicines are being tested as ‘adjunct therapeutics’ along with chemotherapeutic agents, anti-angiogenic molecules, anti-metastatic compounds, and other immune-checkpoint blockers against tumor metastasis/angiogenesis. Hence, a brief note on natural products targeting TAMs was provided. In summary, this review would benefit pharmacologists and medical professionals to develop therapies to target TAMs using multi-OMICs approaches, including genomics, epigenomics, transcriptomics, and proteomics.
Export Options
About this article
Cite this article as:
The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867328666210720143721
DOI https://dx.doi.org/10.2174/0929867328666210720143721 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenomics of Cytochrome P450 Enzymes in Tumours
Current Pharmacogenomics Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Current Signal Transduction Therapy MicroRNAs Regulate the Epithelial to Mesenchymal Transition (EMT) in Cancer Progression
MicroRNA Platinum Group Antitumor Chemistry: Design and development of New Anticancer Drugs Complementary to Cisplatin
Current Medicinal Chemistry Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Telomeres and Thyroid Cancer
Current Genomics The Prevention of Oral Mucositis in Patients with Blood Cancers: Current Concepts and Emerging Landscapes
Cardiovascular & Hematological Agents in Medicinal Chemistry Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer
Current Cancer Drug Targets Ligands and Therapeutic Perspectives of Adenosine A2A Receptors
Current Pharmaceutical Design Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
Current Drug Metabolism Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Bladder Cancer and Stem Cells
Current Signal Transduction Therapy An Overview of Nanoformulated Nutraceuticals and their Therapeutic Approaches
Current Nutrition & Food Science PET Imaging to Monitor Cancer Therapy
Current Pharmaceutical Biotechnology Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry In Situ Gels Based Drug Delivery Systems
Current Drug Therapy Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII
Current Medicinal Chemistry Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry